Alcoholic Hepatitis clinical trials

Explore recruiting alcoholic hepatitis clinical trials.

Recruiting alcoholic hepatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alcoholic Hepatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Utility of the use of N-acetylcysteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

PROlonged Corticosteroid treatment or N-ACetylcysteine for severe alcoholic hepatitis (PROCORNAC)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects with Severe Alcohol-Associated Hepatitis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF).

Germany, Spain, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Alcoholic Hepatitis trials by city

Alcoholic Hepatitis in Toronto Alcoholic Hepatitis in Vancouver Alcoholic Hepatitis in Montreal Alcoholic Hepatitis in Calgary Alcoholic Hepatitis in Edmonton Alcoholic Hepatitis in Ottawa Alcoholic Hepatitis in Winnipeg Alcoholic Hepatitis in Quebec City Alcoholic Hepatitis in Hamilton Alcoholic Hepatitis in Kitchener Alcoholic Hepatitis in London Alcoholic Hepatitis in Halifax Alcoholic Hepatitis in New York Alcoholic Hepatitis in Los Angeles Alcoholic Hepatitis in Chicago Alcoholic Hepatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease